期刊文献+

动脉粥样硬化发生过程中C反应蛋白对内皮细胞功能的影响:量效与时效趋势 被引量:1

Dose-dependent and time-dependent effects of C reactive protein on the endothelial function during the occurrence of atherosclerosis
下载PDF
导出
摘要 目的:探讨C反应蛋白对内皮细胞株304细胞释放前列环素、纤溶酶原激活物抑制剂1的影响。方法:实验于2005-01/2005-04在解放军第305医院老年病中心实验室完成。将内皮细胞株304细胞(第131代)以3×104细胞悬液接种到96孔板中,细胞融合生长后换用含0mg/L(对照组),25和50及100mg/L的C反应蛋白Dulbecco改良的Eagle培养基,作用24h,观察C反应蛋白的量效。加入50mg/LC反应蛋白,作用3,6,12,24h,观察C反应蛋白时间效应。用酶联免疫吸附法检测培养液上清液中前列环素的稳定代谢产物6-酮-前列环素F1α、纤溶酶原激活物抑制剂1的水平。结果:①量效关系:C反应蛋白各质量浓度组纤溶酶原激活物抑制剂1水平明显高于对照组(P<0.01),并随C反应蛋白质量浓度增加而增加,尤以100mg/L浓度较25mg/L时增加明显(P<0.05);C反应蛋白各质量浓度组6-酮-前列腺素F1α水平明显低于对照组(P<0.01),并随C反应蛋白质量浓度增加而下降(P<0.01)。②时效关系:C反应蛋白(50mg/L)作用内皮细胞后,随时间延长纤溶酶原激活物抑制剂1水平呈递增趋势(P<0.05~0.01)。作用12h内6-酮-前列腺素F1α水平随时间延长而呈递增趋势(P<0.01),24h明显小于12h(P<0.05);3h时大于对照组(P<0.05),12和24h时明显少于对照组(P<0.01)。结论:C反应蛋白可能通过抑制前列腺环素生成,促进纤溶酶原激活物抑制剂1释放参与急性冠脉综合征的病理生理过程。损伤刺激内皮细胞早期能增加前列腺环素的释放,以提高对损伤的防御,随着时间的延长,防御机制逐渐耗竭,内皮细胞合成前列腺环素被抑制,释放前列腺环素减少。 AIM:To investigate the effect of C reactive protein on prostaglandin and plasminogen activator inhibitor-1 in endothelial cell strain 304 cells.METHODS:The experiment was carried out in the Military Central Laboratory of Geriatrics,the 305 Hospital of Chinese PLA from January to April 2004.Endothelial cell strain 304 cells(the 131st generation) were inoculated to the 96-cell plate with 3× 104 cell suspension;After growth of cell fusion,the Dulbecco modified Eagle medium containing 0 mg/L(control group),25,50,100 mg/L C reactive protein for 24 hours,and the dose dependent effects of C reactive protein were observed.50 mL C reactive protein was added for 3,6,12 and 24 hours to observe its time dependent effects.The levels of the steady metabolite 6 keto prostaglandin F1 alpha and plasminogen activator inhibitor 1 in the supernatant of culture medium were detected with enzyme linked immunoabsorbent assay(ELISA).RESULTS:① Dose dependent association: The level of plasminogen activator inhibitor 1 was obviously higher in the each mass concentration C reactive protein group than in the control group(P< 0.01),and it was increased with the increase of the mass concentration of C reactive protein, and it was more obvious when the concentration was 100 and 15 mg/L(P< 0.05);The level of 6 keto prostaglandin F1 alpha was obviously lower in each mass concentration C reactive protein group than in the control group(P< 0.01),and it was decreased with the increase of the mass concentration of C reactive protein(P< 0.01).② Time dependent association:After the treatment of C reactive protein(50 mg/L),the level of plasminogen activator inhibitor 1 in endothelial cells was gradually increased with he prolongation of time(P< 0.05 to 0.01);Within 12 hours,the level of 6 keto prostaglandin F1 alpha was gradually increased with the prolongation of time(P< 0.01),it was obviously lower at 24 hours than at 12 hours(P< 0.05);At 3 hours,it was higher than that in the control group(P< 0.05);At 12 and 24 hours,it was markedly lower than that in the control group(P< 0.01).CONCLUSION:C reactive protein may be involved in the pathophysiological process of acute coronary syndrome by inhibiting the generation of prostacyclin and promoting the release of plasminogen activator inhibitor 1.Injury and stimulation of endothelial cells at early stage can increase the release of prostacyclin, and then improve the defense to the injury;With the prolongation of time,the defense mechanism was gradually exhausted,the endothelial cells synthetized prostacyclin is inhibited,and its release was reduced.
出处 《中国临床康复》 CSCD 北大核心 2005年第19期48-49,共2页 Chinese Journal of Clinical Rehabilitation
  • 相关文献

参考文献9

  • 1Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999; 138(5 Pt 2): S419-20.
  • 2Tatam MC,Heinrich J, Junker R, et al. C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris. Eur Heart J 2000; 21(12): 1000-8.
  • 3Yamashita K, Ouchi K, Shirai M, et al. Distribution of chlamydia pneumoniae infection in the athersclerotic artery. Stroke 1998;29:773-8.
  • 4陈忠,马根山,黄峻,朱铁兵,杨志健,王连生,曹克将.早发冠心病患者血浆C反应蛋白与临床表型及冠状动脉病变的关系[J].中国临床康复,2004,8(36):8195-8197. 被引量:5
  • 5Pasceri V, cheng JS, Willerson JT, et al. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 2001;103(21):2531-4.
  • 6Verma S. Li SH, Badiwala MV, et al.Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 2002; 105(16): 1890-6.
  • 7Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000:102 (18): 2165-8.
  • 8Emeis JJ. Kooistra T. Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. J Exp Med 1986: 163:1260-6.
  • 9Devaraj S,Xu DY,Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation 2003; 107(3): 398-4O4.

二级参考文献13

  • 1Nakagomi A, Freedman SB, Geczy CL. Interferon-gamma and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: relationship with age, sex, and hormone replacement treatment. Circulation 2000; 101:1785 -91
  • 2Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336:973 - 9
  • 3Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardio-vascular disease in women. N Engl J Med 2000; 342:836 -43
  • 4Cesari M, Penninx BW, Newman AB, et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 2003; 108(19): 2317-22
  • 5Grewal J, Chan S, Frohlieh J, et al. Assessment of novel risk factors in patients at low risk for cardiovascular events based on Framingham risk stratification. Clin Invest Med 2003; 26 (4): 158 - 65
  • 6Ridker PM, Glyrm RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998: 97:2007 - 11
  • 7Ryan TJ, Faxon DP, Gunnar RM, et al. Guidelines for percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1988; 12:529 -45
  • 8Haverkate F, Thompson SG, Pyke SD, et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997; 349:462 - 6
  • 9Anderson JL, Carlquist JF, Muhlestein JB, et al. Evaluation of C-reactive protein,an inflmmatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol 1998; 32:35 -41
  • 10Luc G, Bard JM, Juhan-Vague I, et al. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study. Arterioscler Thromb Vasc Biol 2003; 23(7): 1255 -61

共引文献4

同被引文献1

  • 1Ross R.Atherosclerosis is an inflammatory disease[J].Am Heart J,1999,138 (52):419-20.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部